Narayana Hrudayalaya Reports Q2 Revenue Of ₹28.4B Versus ₹16.44B YoY

Market snapshot: Narayana Hrudayalaya Limited reported a significant top-line expansion in its Q2 financial results, with quarterly consolidated revenue rising to ₹28.4B compared to ₹16.44B in the corresponding prior-year period. The results reflect strong momentum in operational performance across its hospital network.

Data Snapshot

• Consolidated Q2 revenue stood at ₹28.4B compared to ₹16.44B in the corresponding prior-year quarter.
• Year-on-year revenue expansion reached 72.75% (derived: ₹28.4B vs ₹16.44B).

What's Changed

• Q2 revenue increased to ₹28.4B from ₹16.44B YoY.
• Top-line growth reflects expanded operational scale across hospital clusters.

Key Takeaways

• Narayana Hrudayalaya delivered Q2 consolidated revenue of ₹28.4B.
• Prior-year period revenue of ₹16.44B reflects a strong YoY trajectory.
• Continued operational strength supports core financial performance.

SAHI Perspective

The top-line performance highlights sustained demand for specialized tertiary healthcare services. The expansion in revenue reflects improved operational metrics and capacity utilization across key facility clusters.

Market Implications

Strong revenue expansion signals underlying operational volume strength in the healthcare services sector, reinforcing positive financial health for hospital operations.

Trading Signals

Market Bias: Bullish

Top-line strength with Q2 revenue reaching ₹28.4B versus ₹16.44B YoY demonstrates strong operational performance.

Overweight: Healthcare Services, Hospitals & Diagnostics

Trigger Factors:

• Sustained inpatient volume growth across tertiary facilities
• Monetization of expanded bed capacity
• Operational margin maintenance

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian hospital sector continues to benefit from steady occupancy levels and demand for high-end surgical procedures across tertiary and quaternary care hubs.

Key Risks to Watch

• Cost inflation in medical consumables and staffing
• Regulatory caps or pricing mandates on essential medical procedures

Recent Developments

Narayana Hrudayalaya filed its Q2 FY27 investor presentation with stock exchanges on October 30, 2026.

Closing Insight

With Q2 revenue expanding to ₹28.4B, Narayana Hrudayalaya demonstrates ongoing execution capability in scaling its hospital operations.

High Performance Trading with SAHI.